Lincoln Pharmaceuticals Limited (BOM:531633)
India · Delayed Price · Currency is INR 682.10
+40.85 (6.37%)
At close: May 5, 2026
Lincoln Pharmaceuticals Earnings Call Transcripts
Fiscal Year 2026
-
Q3 FY26 saw strong revenue and profit growth, with exports and new product launches driving performance. Management maintains a 15%-18% EBITDA margin outlook and targets INR 1,000 crore revenue by FY28, supported by expansion in regulated markets and ongoing R&D investments.